MRT00033659
Modify Date: 2025-08-25 07:04:06
MRT00033659 structure
|
Common Name | MRT00033659 | ||
|---|---|---|---|---|
| CAS Number | 1401731-54-1 | Molecular Weight | 266.30 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H14N4O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MRT00033659MRT00033659 is a potent broad-spectrum kinase inhibitor of CK1 (IC50=0.9 µM for CK1δ) and CHK1 (IC50=0.23 µM). MRT00033659, a pyrazolo-pyridine analogue, induces p53 pathway activation and E2F-1 destabilisation[1]. |
| Name | MRT00033659 |
|---|
| Description | MRT00033659 is a potent broad-spectrum kinase inhibitor of CK1 (IC50=0.9 µM for CK1δ) and CHK1 (IC50=0.23 µM). MRT00033659, a pyrazolo-pyridine analogue, induces p53 pathway activation and E2F-1 destabilisation[1]. |
|---|---|
| Related Catalog | |
| Target |
CKIδ:0.9 μM (IC50) Chk1:0.23 μM (IC50) |
| In Vitro | MRT00033659 (5-40 µM; 48 hours) is sufficient to significantly reduce cell number of 5 µM[1]. MRT00033659 (1-80 µM; 48 hours) induces substantial cell death from 5 µM[1]. MRT00033659 (0.2-80 µM; 48 hours) induces a robust and sustained stabilisation of p53, MDM2 and p21 proteins, as well as E2F-1 destabilisation from 0.2 µM to 5 µM[1]. MRT00033659 does not inhibit p38α MAPK[1]. Cell Viability Assay[1] Cell Line: A375 cells Concentration: 5, 20, 40 µM Incubation Time: 48 hours Result: Significantly reduced cell number of 5 µM. Apoptosis Analysis[1] Cell Line: A375 cells Concentration: 1, 5, 10, 20, 40, 80 µM Incubation Time: 48 hours Result: Induced substantial cell death from 5 µM. Western Blot Analysis[1] Cell Line: A375 cells Concentration: 0.2, 1, 5, 10, 20, 40, 80 µM Incubation Time: 48 hours Result: Induced a robust and sustained stabilisation of p53, MDM2 and p21 proteins, as well as E2F-1 destabilisation from 0.2 µM to 5 µM. |
| References |
| Molecular Formula | C15H14N4O |
|---|---|
| Molecular Weight | 266.30 |